FDA Bans CFC Inhalers, Walmart Offers Low-Cost Alternative
An FDA mandate that came into effect on Dec. 31 dictates that all albuterol metered-dose asthma inhalers marketed in the U.S. must use hydrofluroalkane (HFA) propellants, as opposed to chlorofluorocarbon (CFC) propellants.
Most manufacturers, like GlaxoSmithKline (GSK) and Schering-Plough, hurried to make the transition and have increased production to ensure an adequate supply of HFA inhalers. Armstrong Pharmaceuticals has not yet done so, the FDA said.
Rescue inhalers can be costly: some HFA inhalers may sell for as much as $60 for certain brands. To make the life-saving medication affordable, Walmart is going to sell the ReliOn Ventolin HFA inhaler for $9.
Energy Manager News
- In Duluth, This Month’s Utility Bills Include a Little Something Extra
- PSEG Surreptitiously Starts Retail Energy Supplier
- New Refrigerant Rules Will Have Long Term Impact
- Building Data Platform from Leviton
- Athens, OH, Nears $4.28M Retrofit Project
- ERC Price Benchmark Trends Week Ending: September 23, 2016
- Feds Asked to Reverse Montana PSC Decision on Solar Charges
- Energy Retailer Crius Acquires Assets of Verengo